Prognostic Impact of Baseline Potassium Abnormalities in Patients with Heart Failure with Reduced Ejection Fraction: A Real-World Cohort Study
Medical Sciences · 18.07.2026 · 14 (3) · 402
DOI: 10.3390/medsci14030402 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Medical Sciences, online erschienen am 18.07.2026. Verfasst von Alvaro Roldan-Guerra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Heart Failure Unit, Cardiology Service, Reina Sofia University Hospital, 14004 Cordoba, Spain. Hauptthemen laut MEDLINE: Heart Failure, Potassium, Stroke Volume, Hypokalemia. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Introduction
Abnormal serum potassium levels are a common issue in patients with heart failure with reduced ejection fraction (HFrEF), limiting the use of prognostically beneficial therapies. The primary aim of this study was to characterise the HFrEF population according to baseline potassium levels and to assess their impact on medium- to long-term prognosis.
Methods
A retrospective study was conducted on a cohort of consecutive patients with HFrEF recruited at our centre. Patients were classified according to baseline serum potassium levels into: Group 1 (5.0 mEq/L). Prognostic impact was assessed in terms of HF readmissions, HF mortality and all-cause mortality.
Results
A total of 409 patients were analysed. The median age was 69 years [IQR 59–77], with a predominance of male patients (74.1%). There were 26 patients (6.36%) with hypokalaemia, 365 (89.24%) with normokalaemia, and 18 (4.4%) with hyperkalaemia. Group 1 showed a higher prevalence of diabetes mellitus (69.2% vs. 47.4% vs. 33.4%; p = 0.043) and a greater proportion of patients with ≥2 previous admissions for HF (25% vs. 10.5% vs. 0%; p = 0.008). No differences were observed regarding echocardiographic parameters, markers of congestion, or HFrEF treatment. After a median follow-up of 60 months, no significant differences were found between groups in rates of HF readmissions, HF mortality and all-cause mortality.
Conclusions
Patients with hypokalaemia exhibited a higher prevalence of diabetes mellitus and previous HF admissions. In our population, no differences were observed between groups in the use of prognostically beneficial therapies or in outcomes in terms of HF rehospitalisations and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Failure Unit, Cardiology Service, Reina Sofia University Hospital, 14004 Cordoba, Spain.
- Instituto de Investigación Biomédica de Córdoba, IMIBIC (Instituto Maimonides de Investigacion Biomedica de Cordoba), 14004 Cordoba, Spain.
ORCID-Profile: Alvaro Roldan-Guerra, Jorge Perea-Armijo, Rafael González-Manzanares, Juan Carlos Castillo-Domínguez, Manuel Pan-Álvarez Ossorio, José López-Aguilera
Zitieren
APA
Roldan-Guerra, A., Perea-Armijo, J., González-Manzanares, R., Castillo-Domínguez, J. C., Crespin-Crespin, M., Pan-Álvarez Ossorio, M., Anguita-Sánchez, M., & López-Aguilera, J. (2026). Prognostic Impact of Baseline Potassium Abnormalities in Patients with Heart Failure with Reduced Ejection Fraction: A Real-World Cohort Study. Medical Sciences, 14(3), 402. https://doi.org/10.3390/medsci14030402
Vancouver
Roldan-Guerra A, Perea-Armijo J, González-Manzanares R, Castillo-Domínguez JC, Crespin-Crespin M, Pan-Álvarez Ossorio M, et al. Prognostic Impact of Baseline Potassium Abnormalities in Patients with Heart Failure with Reduced Ejection Fraction: A Real-World Cohort Study. Medical Sciences. 2026;14(3):402. doi:10.3390/medsci14030402
BibTeX
@article{RoldanGuerra2026,
author = {Roldan-Guerra, Alvaro and Perea-Armijo, Jorge and González-Manzanares, Rafael and Castillo-Domínguez, Juan Carlos and Crespin-Crespin, Manuel and Pan-Álvarez Ossorio, Manuel and Anguita-Sánchez, Manuel and López-Aguilera, José},
title = {Prognostic Impact of Baseline Potassium Abnormalities in Patients with Heart Failure with Reduced Ejection Fraction: A Real-World Cohort Study},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {3},
pages = {402},
doi = {10.3390/medsci14030402}
}
EUVIMED